These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11194 related articles for article (PubMed ID: 15638382)
1. Expression of PCNA and Ki-67 in posterior uveal melanomas in adults. Proniewska-Skretek E; Dziecioł J; Zalewska R; Mariak Z Rocz Akad Med Bialymst; 2004; 49 Suppl 1():79-81. PubMed ID: 15638382 [TBL] [Abstract][Full Text] [Related]
2. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma. Seregard S; Oskarsson M; Spångberg B Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1451-8. PubMed ID: 8641848 [TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma. Ghazvini S; Kroll S; Char DH; Frigillana H Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099 [TBL] [Abstract][Full Text] [Related]
4. [Correlations of Ki-67 expression and histopathologic characteristics in uveal melanomas]. Liang J; Yi C; Schilling H; Li X Yan Ke Xue Bao; 2001 Jun; 17(2):114-7, 132. PubMed ID: 12567765 [TBL] [Abstract][Full Text] [Related]
5. [Expression of bcl-2, Ki-67 and p-53 in uveal melanomas]. Krvavica A; Talan-Hranilović J; Belicza M Acta Med Croatica; 2008 Jul; 62(3):267-71. PubMed ID: 18843846 [TBL] [Abstract][Full Text] [Related]
6. An evaluation of Ki-67 and PCNA expression in conjunctival and eyelid tumours. Reszeć J; Kańczuga-Koda L; Sulkowska M; Koda M; Cylwik J; Barwijuk-Machała M; Sulkowski S Folia Morphol (Warsz); 2004 Feb; 63(1):95-8. PubMed ID: 15039910 [TBL] [Abstract][Full Text] [Related]
7. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer. Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314 [TBL] [Abstract][Full Text] [Related]
8. [Study of a role of the expression of a transmembranous CD117/C-Kit receptor in the progression of uveal melanomas]. Anurova OA; Likhvantseva VG; Vereshchagina MV Vestn Oftalmol; 2007; 123(5):41-4. PubMed ID: 18078058 [TBL] [Abstract][Full Text] [Related]
9. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study. Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966 [TBL] [Abstract][Full Text] [Related]
10. PCNA-LII, Ki-67 immunostaining, p53 activity and histopathological variables in predicting the clinical outcome in patients with parathyroid carcinoma. Lumachi F; Ermani M; Marino F; Iacobone M; Baldessin M; Cappuzzo G; Zanella S; Favia G Anticancer Res; 2006; 26(2A):1305-8. PubMed ID: 16619538 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of Ki-67, PCNA and S6K1/2 expression in human breast cancer. Lyzogubov V; Khozhaenko Y; Usenko V; Antonjuk S; Ovcharenko G; Tikhonkova I; Filonenko V Exp Oncol; 2005 Jun; 27(2):141-4. PubMed ID: 15995633 [TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic significance of proliferating cell nuclear antigen and Ki-67 in malignant ovarian germ cell tumors. Liu FS; Chen JT; Liu SC; Shih A; Shih RT; Ho ES Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct; 62(10):695-702. PubMed ID: 10533299 [TBL] [Abstract][Full Text] [Related]
13. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors. Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575 [TBL] [Abstract][Full Text] [Related]
14. Expression and distribution of MMPs and TIMPs in human uveal melanoma. Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620 [TBL] [Abstract][Full Text] [Related]
15. Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas. Chiquet C; Grange JD; Ayzac L; Chauvel P; Patricot LM; Devouassoux-Shisheboran M Br J Ophthalmol; 2000 Jan; 84(1):98-102. PubMed ID: 10611107 [TBL] [Abstract][Full Text] [Related]
16. Analysis of inflammatory cells in uveal melanoma after prior irradiation. Vu TH; Bronkhorst IH; Versluis M; Marinkovic M; van Duinen SG; Vrolijk J; Luyten GP; Jager MJ Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):360-9. PubMed ID: 23211827 [TBL] [Abstract][Full Text] [Related]
17. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors. Al-Jamal RT; Kivelä T Curr Eye Res; 2006 Jan; 31(1):57-67. PubMed ID: 16421020 [TBL] [Abstract][Full Text] [Related]
18. A histologic study (including DNA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques. Schilling H; Sehu KW; Lee WR Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2081-92. PubMed ID: 9331272 [TBL] [Abstract][Full Text] [Related]
19. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related]
20. [Intratumoral blood pools and prognosis of malignant uveal melanoma treated with enucleation]. Kantelip B; Albuisson E; Bacin F; Bonhomme R Ophtalmologie; 1989; 3(1):49-52. PubMed ID: 2641072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]